Remicade and Naltrexone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Remicade (infliximab) and Naltrexone (naltrexone). Common drug interactions include infusion related reaction among females and pain among males.

The phase IV clinical study analyzes what interactions people have when they take Remicade and Naltrexone. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Remicade?

Remicade has active ingredients of infliximab. It is often used in crohn's disease. eHealthMe is studying from 224,011 Remicade users. Check the latest studies of Remicade.

What is Naltrexone?

Naltrexone has active ingredients of naltrexone. eHealthMe is studying from 4,833 Naltrexone users. Check the latest studies of Naltrexone.



On Jul, 14, 2026

19 people who take Remicade and Naltrexone together, and have interactions are studied.

Remicade and Naltrexone drug interactions.

What are the common drug interactions of Remicade and Naltrexone, by gender? *:

female:

  1. Infusion related reaction
  2. Dyspnoea (difficult or laboured respiration)
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Pruritus (severe itching of the skin)
  5. Arthritis (form of joint disorder that involves inflammation of one or more joints)
  6. Blood pressure fluctuation
  7. Brain neoplasm (tumour of brain)
  8. Iritis (painful inflammation of the iris of the eye)
  9. Hypertension (high blood pressure)
  10. Abdominal pain

male:

  1. Pain
  2. Colitis (inflammation of colon)
  3. Inflammatory bowel disease
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Nasopharyngitis (inflammation of the nasopharynx)
  6. Pyrexia (fever)
  7. Viral infection
  8. Bacterial infection
  9. Abdominal adhesions (inflammation of abdomen)
  10. Anal inflammation

What are the common drug interactions of Remicade and Naltrexone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Bacterial infection

20-29:

  1. Abdominal pain
  2. Anaphylactic reaction (serious allergic reaction)
  3. Blood pressure fluctuation
  4. Chest discomfort
  5. Dysphagia (a condition in which swallowing is difficult or painful)
  6. Dyspnoea (difficult or laboured respiration)
  7. Erythema (redness of the skin)
  8. Flushing (the warm, red condition of human skin)
  9. Hypotension (abnormally low blood pressure)
  10. Infusion related reaction

30-39:

  1. Bile duct stenosis (abnormal narrowing of the common bile duct)
  2. Biliary dilatation
  3. Bowel movement irregularity
  4. Cellulitis (infection under the skin)
  5. Cholangitis sclerosing (infection and obstruction of bile duct)
  6. Colitis (inflammation of colon)
  7. Drug hypersensitivity
  8. Drug ineffective
  9. Frequent bowel movements
  10. Hepatic enzyme increased

40-49:

  1. Hypertension (high blood pressure)
  2. Infusion related reaction
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Pruritus (severe itching of the skin)
  5. Arthralgia (joint pain)
  6. Blood pressure fluctuation
  7. Brain neoplasm (tumour of brain)
  8. Dyspnoea (difficult or laboured respiration)

50-59:

  1. Burning sensation
  2. Cough
  3. Herpes zoster
  4. Lower respiratory tract infection
  5. Pain
  6. Pruritus (severe itching of the skin)

60+:

  1. Confusional state
  2. Memory impairment

What are the existing conditions these people have? *

  1. Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 3 people, 15.79%
  2. Inflammatory Bowel Disease: 2 people, 10.53%
  3. Weight Decreased: 1 person, 5.26%
  4. Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 5.26%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.26%
  6. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Remicade and Naltrexone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Remicade and Naltrexone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Remicade:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naltrexone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Remicade and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naltrexone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on infliximab and naltrexone (the active ingredients of Remicade and Naltrexone, respectively), and Remicade and Naltrexone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: